Story perspectives

Study Links Epilepsy Medications and Genetics to Obesity Risks

4/7/2026

Summary

Story summary

New research led by Wang et al. shows that genetic predisposition, antiseizure medications, and lifestyle factors influence obesity in epilepsy patients.
The study identifies valproate as a factor that can exacerbate weight gain.
Lifestyle interventions may mitigate obesity risks, underscoring the need for personalized treatment that accounts for genetics.
The findings suggest a shift in epilepsy care toward integrating metabolic health with seizure management to improve outcomes globally.

1 of 1

Story summary

New research led by Wang et al. shows that genetic predisposition, antiseizure medications, and lifestyle factors influence obesity in epilepsy patients.
The study identifies valproate as a factor that can exacerbate weight gain.
Lifestyle interventions may mitigate obesity risks, underscoring the need for personalized treatment that accounts for genetics.
The findings suggest a shift in epilepsy care toward integrating metabolic health with seizure management to improve outcomes globally.